EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells

The adverse prognosis of most patients with ovarian cancer is related to recurrent disease caused by resistance to chemotherapeutic and targeted therapeutics. Besides their direct activity against tumor cells, monoclonal antibodies and tyrosine kinase inhibitors (TKIs) also influence the antitumoral...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallmann-Gottschalk, Nina, Sax, Yvonne, Kimmig, Rainer, Lang, Stephan, Brandau, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801374/
https://www.ncbi.nlm.nih.gov/pubmed/31546690
http://dx.doi.org/10.3390/ijms20194693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801374/
https://www.ncbi.nlm.nih.gov/pubmed/31546690
http://dx.doi.org/10.3390/ijms20194693

Ejemplares similares